This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Palanzo, D. A Articles by Manley, N. J Search for Related Content PubMed PubMed Citation Articles by Palanzo, D. A Articles by Manley, N. J Social Bookmarking                   What's this?

Albumin in the cardiopulmonary bypass prime: how little is enough?

Lehigh Valley Hospital, Allentown, Pennsylvania, David.Palanzo{at}LVH.com

Debra L Zarro

Lehigh Valley Hospital, Allentown, Pennsylvania

Ralph M Montesano

Lehigh Valley Hospital, Allentown, Pennsylvania

Norman J Manley

Lehigh Valley Hospital, Allentown, Pennsylvania

Previous studies have demonstrated high transoxygenator pressures with noncoated hollow-fiber membrane oxygenators. These reports have been associated with dramatic platelet count drops during cardiopulmonary bypass (CPB). It has also been shown that adding human albumin to the prime of the bypass circuit reduces, if not eliminates, these problems. This study was conducted to determine what is the smallest amount of albumin added to the prime that will still display its protective effects. Eighty patients undergoing nonemergency open-heart surgery were randomly divided into four groups. Groups I and II received the Sarns Turbo 440 oxygenator with 0.0375 g of albumin/100 ml of prime and 0.125 g of albumin/100 ml of prime, respectively, added to the pump prime. Groups III and IV received the Medtronic Maxima-PRF oxygenator with 0.0375 g of albumin/100 ml of prime and 0.125 g of albumin/100 ml of prime, respectively, added to the pump prime. Pre-CPB, on CPB (15-20 min after the initiation of bypass) and warming hemoglobin, hematocrit and platelet counts were drawn on all patients. Net platelet count drop, which accounted for hemodilutional effects, was calculated for all specimens and compared to previous results obtained from the test oxygenators without albumin in the prime. The net platelet count drops for the study groups were as follows:

• Sarns oxygenator with no albumin in the prime = 11.8 ± 12.5%;

• Sarns oxygenator with 0.0375 g of albumin/100 ml prime = -3.7 ± 10.8%;

• Sarns oxygenator with 0.125 g of albumin/100 ml prime = -2.0 ± 12.6%;

• Medtronic oxygenator with no albumin in the prime = 20.1 ± 14.5%;

• Medtronic oxygenator with 0.0375 g albumin/100 ml prime = -6.9 ± 8.7%; and

• Medtronic oxygenator with 0.125 g albumin/100 ml prime = -14.0 ± 12.4%.

Our results illustrate that adding as little as 0.0375 g albumin/100 ml prime (3 ml of 25% solution/2000 ml of prime) to the pump prime illicits the beneficial effects of surface coating on platelet loss during CPB.

Perfusion, Vol. 14, No. 3, 167-172 (1999)
DOI: 10.1177/026765919901400303


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. R. Fisher, M. Baker, M. Buffin, P. Campbell, S. Hansbro, S. Kennington, A. Lilley, and M. Whitehorne Normal and abnormal trans-oxygenator pressure gradients during cardiopulmonary bypass Perfusion, January 1, 2003; 18(1): 25 - 30. [Abstract] [PDF]

				R C Groom, R J Forest, J E Cormack, K S Niimi, and J Morton Parallel replacement of the oxygenator that is not transferring oxygen: the PRONTO procedure Perfusion, December 1, 2002; 17(6): 447 - 450. [Abstract] [PDF]

				R. H. Boks, L. A. van Herwerden, J. J.M. Takkenberg, W. van Oeveren, Y. J. Gu, M. J. Wijers, and A. J.J.C. Bogers Is the use of albumin in colloid prime solution of cardiopulmonary bypass circuit justified? Ann. Thorac. Surg., September 1, 2001; 72(3): 850 - 853. [Abstract] [Full Text] [PDF]

				D. A Palanzo, D. L Zarro, N. J Manley, R. M Montesano, M. Quinn, B.-A. Elmore, P. A Gustafson, and J. M Castagna Effect of Carmeda(R) BioActive Surface coating versus TrilliumTM Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass Perfusion, July 1, 2001; 16(4): 279 - 283. [Abstract] [PDF]

				D. L Zarro, D. A Palanzo, and T. G Phillips Albumin in the pump prime: its effect on postoperative weight gain Perfusion, March 1, 2001; 16(2): 129 - 135. [Abstract] [PDF]

				H. Luckraz, D. Boolauky, and A. Mohangee Cryofibrination: did it really happen? Perfusion, January 1, 2001; 16(1): 83 - 86. [Abstract] [PDF]

				D. A Palanzo, D. L Zarro, R. M Montesano, N. J Manley, M. Quinn, B.-A. Elmore, P. A Gustafson, and J. M Castagna Effect of TrilliumTM Biopassive Surface coating of the oxygenator on platelet count drop during cardiopulmonary bypass Perfusion, December 1, 1999; 14(6): 473 - 479. [Abstract] [PDF]